Pharma-Bio Serv (PBSV) Debt Ratio (2020 - 2021)
Pharma-Bio Serv's (PBSV) quarterly Debt Ratio came in at 0.07 in Q2 2021, up 2.64% YoY from 0.07 in Q2 2020, and up 8.24% on a QoQ basis from 0.06 in Q1 2021.
Pharma-Bio Serv (PBSV) Debt Ratio (2020 - 2021) Analysis & Trends
Pharma-Bio Serv (PBSV) has 2 years of Debt Ratio data on file, last reported at 0.07 in Q2 2021.
- Quarterly Debt Ratio rose 2.64% year-over-year to 0.07 in Q2 2021, while the trailing twelve-month figure through Apr 2021 was 0.07 (up 2.64% YoY) and the FY2020 annual result came in at 0.06, changed N/A from the prior year.
- Debt Ratio improved to 0.07 in Q2 2021, from 0.06 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.07 in Q2 2021 to a low of 0.06 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 0.37 |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 0.29 |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 0.25 |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 0.07 |
| Jan 31, 2021 | 0.06 |
| Oct 31, 2020 | 0.06 |
| Jul 31, 2020 | 0.06 |
| Apr 30, 2020 | 0.07 |